{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:07:57Z","timestamp":1776834477517,"version":"3.51.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Observational studies on the association between specific lipid parameters\u2014such as triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C)\u2014and the risk of diabetic nephropathy (DN) have yielded inconsistent and sometimes controversial conclusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study systematically searched relevant literature in PubMed, Embase, Web of Science, and the Cochrane Library up to October 2025. Statistical analysis was performed using Review Manager 5.4.1 software. The pooled odds ratio and its 95% confidence interval were calculated using a random-effects model. Heterogeneity was assessed using the chi-square test and I\u00b2 statistic, and publication bias was assessed using funnel plots and Egger regression tests. The effect of publication bias was analyzed using the trim-and-fill method, and the robustness of the results was examined through sensitivity analysis. Evidence for each outcome was evaluated and graded according to GRADE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 15 studies were included in the meta-analysis. The results showed that higher serum TG levels were significantly associated with an increased risk of DN (OR = 1.17, 95% CI: 1.11\u20131.23, P &amp;lt; 0.00001). Higher TC levels also indicated a slight increased risk (OR = 1.06, 95% CI: 1.01\u20131.11, P = 0.01). HDL-C showed a protective effect (OR = 0.86, 95% CI: 0.81\u20130.92, P &amp;lt; 0.00001). No significant association was found between LDL-C and the risk of DN. Egger\u2019s test suggested publication bias for TG and HDL-C, but the magnitude of strength did not change direction after trimming and filling. Sensitivity analysis showed that the above findings were robust. Regarding the GRADE rating, all outcomes were rated as very low-quality evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated serum TG levels are a risk factor for DN, while HDL-C shows a protective effect. While TC showed a positive correlation, the effect was weak; LDL-C did not show a significant association. Future research should focus on prospective cohort designs to validate causal associations and explore the potential value of lipid-lowering therapy in the primary prevention of DN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1783038","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:33:27Z","timestamp":1776832407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between serum lipid levels and the risk of diabetic nephropathy: a meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Linli","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, West China Hospital of Sichuan University","place":["Chengdu, China"]},{"name":"Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University","place":["Chengdu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70159","article-title":"Diabetic kidney disease\u2010associated pathological angiogenesis: The role of aquaporin\u20101","volume":"17","author":"Zhang","year":"2025","journal-title":"J Diabetes"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.36347\/sjams.2025.v13i09.011","article-title":"Prevalence of microvascular complications in diabetes mellitus patients attending a nephrology outpatient department at a tertiary care hospital in Bangladesh","volume-title":"Sch J App Med Sci","author":"Jahan","year":"2025"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1513008","article-title":"Global burden of chronic kidney disease due to diabetes mellitus, 1990-2021, and projections to 2050","volume":"16","author":"Ma","year":"2025","journal-title":"Front Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1602594","article-title":"Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy","volume":"16","author":"Hou","year":"2025","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s530737","article-title":"The lipid-oxidative stress axis: Novel therapeutic targets for podocytopathy","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflammation Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92949","article-title":"Hypertensive nephrosclerosis: Pathological changes and overlap with diabetic nephropathy","volume":"17","author":"Qasim","year":"2025","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1559026","article-title":"An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease","volume":"16","author":"Feng","year":"2025","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.70086","article-title":"The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy","volume":"16","author":"\u00c7atak","year":"2025","journal-title":"J Diabetes Invest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.4686","article-title":"Association between atherogenic, thrombogenic, and lipophilic indices and the odds of diabetic nephropathy in type 2 diabetic patients: A case-control study","volume":"13","author":"Abbasi","year":"2025","journal-title":"Food Sci Nutr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03815-7","article-title":"Establishment and validation of a diagnostic model for diabetic nephropathy in type 2 diabetes mellitus","volume":"56","author":"Xing","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12944-025-02632-4","article-title":"Sex-specific and metabolic subgroup heterogeneity in high-density lipoprotein cholesterol associations with diabetic kidney disease risk: A retrospective cohort study","volume":"24","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1038\/s41598-024-57723-6","article-title":"Prevalence of diabetic kidney disease and the associated factors among patients with type 2 diabetes in a multi-ethnic Asian country","volume":"14","author":"Wan","year":"2024","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060238","article-title":"The analysis of risk factors for diabetic kidney disease progression: A single-centre and cross-sectional experiment in Shanghai","volume":"12","author":"Liu","year":"2022","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14502\/v2\/response1","article-title":"High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study","volume":"23","author":"Gong","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1503711","article-title":"Lipid abnormality in diabetic kidney disease and potential treatment advancements","volume":"16","author":"Tu","year":"2025","journal-title":"Front Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1509884","article-title":"Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism","volume":"12","author":"Liu","year":"2025","journal-title":"Front Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s44411-025-00189-3","article-title":"Metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: Unraveling connections and advancing therapies","volume":"126","author":"Lian","year":"2025","journal-title":"Bratislava Med J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/acph-2025-0002","article-title":"The impact of blood lipids and statins on renal function and mortality in patients with diabetic nephropathy: A meta-analysis","volume":"75","author":"Tian","year":"2025","journal-title":"Acta Pharm"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.31222\/osf.io\/v7gm2","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Res Ed)"},{"key":"B20","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses\n          \n          \n            \n              Wells\n              G\n            \n            \n              Shea\n              B\n            \n            \n              O'Connell\n              D\n            \n            \n              Peterson\n              J\n            \n            \n              Welch\n              V\n            \n            \n              Losos\n              M\n            \n          \n          \n          2011"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040826","article-title":"Effect of red, processed, and white meat consumption on the risk of gastric cancer: An overall and dose-response meta-analysis","volume":"11","author":"Kim","year":"2019","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1191\/026921699666884611","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102412","article-title":"Efficacy of e-health interventions for smoking cessation management in smokers: A systematic review and meta-analysis","volume":"68","author":"Li","year":"2024","journal-title":"EClinicalMedicine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Res Ed)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.279940","article-title":"Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: Incidence and associations","volume":"31","author":"Aboelnasr","year":"2020","journal-title":"Saudi J Kidney Dis Transplantation: Off Publ Saudi Center For Organ Transplantation Saudi Arabia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2014.38.2.109","article-title":"Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey","volume":"38","author":"Ahn","year":"2014","journal-title":"Diabetes Metab J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1476_24","article-title":"Prevalence and risk factors of diabetic nephropathy among type 2 diabetes patients in family medicine clinic AFHSR Khamis Mushait","volume":"14","author":"Al-Shahrani","year":"2025","journal-title":"J Family Med Primary Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1124367","article-title":"Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus","volume":"14","author":"Dejenie","year":"2023","journal-title":"Front Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12882-021-02429-4","article-title":"Diabetic kidney disease in patients with type 2 diabetes mellitus: A cross-sectional study","volume":"22","author":"Farah","year":"2021","journal-title":"BMC Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0306","article-title":"Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: Results of the ADVANCE study","volume":"35","author":"Morton","year":"2012","journal-title":"Diabetes Care"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1246","article-title":"Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: The AMD Annals Initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12882-025-04546-w","article-title":"The relationship between serum lipid levels and diabetic nephropathy in patients with primary diabetes","volume":"26","author":"Wang","year":"2025","journal-title":"BMC Nephrol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102840","article-title":"A non-linear association between low-density lipoprotein cholesterol and the risk of diabetic kidney disease in patients with type 2 diabetes in China","volume":"45","author":"Xiang","year":"2024","journal-title":"Prev Med Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-0970-2","article-title":"Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China","volume":"18","author":"Yang","year":"2019","journal-title":"Lipids Health Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/ijgm.s363474","article-title":"Development and validation of a model that predicts the risk of diabetic nephropathy in type 2 diabetes mellitus patients: A cross-sectional study","volume":"15","author":"Yang","year":"2022","journal-title":"Int J Gen Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073072","article-title":"Targeting inflammatory imbalance in chronic kidney disease: Focus on anti-inflammatory and resolution mediators","volume":"26","author":"Rispoli","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfag050","article-title":"Clinical phenotype and prognosis of patients with diabetic kidney disease complicated by a primary podocytopathy","author":"Zhou","year":"2026","journal-title":"Nephrol Dialysis Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146962","article-title":"Lipid accumulation and insulin resistance: Bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease","volume":"26","author":"Cao","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041683","article-title":"High-density lipoprotein in patients with diabetic kidney disease: Friend or foe","volume":"26","author":"Liu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"65662","DOI":"10.5551\/jat.65662","article-title":"Cholesterol efflux capacity and anti-oxidative activity of high-density lipoprotein in chronic kidney disease","volume":"26","author":"Suzuki","year":"2025","journal-title":"J Atheroscl Thromb"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/nu17071125","article-title":"The non-high-density lipoprotein cholesterol (non-HDL-C) to HDL-C ratio (NHHR) and its association with chronic kidney disease in Chinese adults with type 2 diabetes: A preliminary study","volume":"17","author":"Chen","year":"2025","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvag001","article-title":"Assessment of N\/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation","volume":"17","author":"Di Giacomo Barbagallo","year":"2026","journal-title":"J Endocr Soc"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16005","article-title":"Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy","volume":"44","author":"Scilletta","year":"2024","journal-title":"Liver International: Off J Int Assoc For Study Liver"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1783038\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:33:44Z","timestamp":1776832424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1783038\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":44,"alternative-id":["10.3389\/fendo.2026.1783038"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1783038","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1783038"}}